Resumo

Pacientes pediátricos, principalmente internados em unidades de terapia intensiva (UTI) neonatal, são altamente vulneráveis aos erros de medicação. O objetivo deste trabalho foi conhecer a frequência dos erros de prescrição em uma UTI neonatal de um hospital universitário, bem como os pacientes susceptíveis, os tipos de erros e os medicamentos envolvidos. As variáveis prescritas relacionadas aos medicamentos foram comparadas com a base utilizada como referência para a prescrição na unidade (Neofax). Participaram do estudo 150 recém-nascidos. Foram analisadas 489 prescrições, 1.491 itens de medicamentos, correspondendo a 46 fármacos. A taxa de erros de prescrição foi de 43,5%. Foram encontrados erros de dose, intervalo, diluente e tempo de infusão, distribuídos em sete classes terapêuticas. A ocorrência de erros foi maior em recém-nascidos pré-termos. Os erros de diluente e de dose foram os mais frequentes. As classes de medicamentos mais envolvidas nos erros foram os anti-infecciosos e aqueles que atuam nos sistemas nervoso e cardiovascular.
Introduction
Pediatric patients, especially those admitted to neonatal intensive care units (ICU), are highly vulnerable to medication errors 1, 2, 3 . The immaturity of organs causes difficulties for neonates, especially the very premature, to adapt to extra uterine life, because they often have multiple morbidities and need complex and intensive medical care. This exposes them to a high number of prescriptions, and a greater risk of adverse reactions 4 .
The repertoire of prescribed drugs in the neonatal ICU is relatively limited compared to the ICU, whether pediatric or adult, however the process of prescribing, dispensing and administrating drugs is much more complex 2 . Although advances in clinical trials for medications in pediatrics have increased considerably in recent years, the use of off label drugs remains a major public health problem for newborns, particularly for preterm newborns and children with rare diseases, which makes the use of off label drugs a common and necessary practice when there is no pharmacological alternative 5 . The necessity of using weight and body surface in the calculation of doses and pharmacological factors such as variation in the rate of absorption, metabolism and excretion of drugs, make the drug therapy more prone to errors in this population 1, 2, 6 . In addition, children and especially newborns have lower internal reserves compared to adults, and therefore are less able to mitigate errors 1, 2, 7 .
Studies in developed countries have shown that most errors occur during the prescription 1, 7, 8, 9 . One of the challenges of the prescription process is that most drugs are available only in formulations and concentrations for adults and must be diluted or modified for use in children, requiring a larger number of calculations and thereby increasing the likelihood of errors 10, 11 . In addition, some medications used in the neonatal ICU have complex doses, with very strict intervals and a narrow therapeutic index 12 , and if they are not properly prescribed can cause severe injury or even death 13 .
Although the errors involve people, human failures are only a small part of the problem. According to Reason 14 , human beings are fallible and errors are to be expected even in the best organizations. Thus, in the hospital environment errors should be treated as deviations from the drug use process 6 and strategies for their prevention are necessary.
Considering the peculiarities of newborns and their vulnerability to medication errors, this study aimed to assess the frequencies of prescribing errors in a neonatal ICU, as well as the characteristics of susceptible patients, the types of errors, and the drugs involved.
Methods
This single-centered retrospective study was previously approved by the Ethics Research Committee of the Federal University of Uberlândia, under protocol 321/11. Data of newborns admitted to the neonatal ICU of a federal university hospital in the Triângulo Mineiro region of the state of Minas Gerais, Brazil, from January 2011 to September 2011 were collected.
Population
The study population consisted of 151 patients. The study included newborns with a minimum stay of 24 hours in the neonatal ICU and who have had at least one prescribed drug. In cases of readmission, the newborn was recorded as a new patient. Newborns were classified according to gestational age (GA) in preterms (GA < 37 weeks) and terms (GA ≥ 37 weeks) 15 .
Sample
The data was collected from prescription order forms containing at least one drug prescribed for infants who remained at least 24 hours in the unit. Since this is a retrospective study, the period of January to September 2011 was chosen for the data collection. Upon completion of the collection, all data collected in the period was analyzed.
Place of study
The study was conducted in the neonatal ICU of a federal teaching hospital considered as reference in the region. Prescriptions were manually written every 24 hours and reviewed by the medical staff as needed. The medical and nursing teams have defined protocols for patient care, including the use of diluents and infusion rate for some medications. All medications are prepared by the nursing staff. The hospital pharmacy service of this hospital does not have a unit dose distribution system. The unit has no clinical pharmacist, and when necessary, information is requested from the clinical hospital pharmacy service.
Data collection
Data of prescribed drugs were collected from prescription order forms at four different times during the hospitalization: the first 24 hours, the 3rd and 5th days of hospitalization and at discharge from the unit. The early neonatal period was chosen because it is considered a critical period of stay in the neonatal ICU 16 . The time of discharge was chosen to compare the error rates in this phase with the other moments of hospitalization. In case of death or transfer of the newborn to another unit, only the prescribed drugs of the period in which the newborn remained in the unit were considered.
The following data referring to neonates were collected: date of birth and hospitalization, GA, postmenstrual or corrected age, chronological age, gender, weight at admission, weight on each day of prescription and severity score (SNAPPE II -Score for Neonatal Acute Physiology, Perinatal Extension, Version II) 17 . Regarding the prescribed drugs, the variables dose, interval, route of administration, diluents, and infusion rate, were collected. Formulations for parenteral nutrition, serotherapy, electrolytes, oxygen administration, blood products, vaccines, vitamins, contrasts, and topical products, were excluded from the analysis.
The term medication item was used for each item of prescribed drug.
All data were collected and analyzed by a pharmacist belonging to the team of researchers.
Medication errors and prescribing errors
Medication errors include prescribing errors, dispensing errors, medication administration errors, and patient compliance errors 18 . For this study, the prescribing error was defined as an error that occurs at the stage of prescribing. Errors during dispensing or administering medication and the correct relationship and drug therapy were not evaluated.
All variables related to the prescribed drugs were compared with the Neofax database, which is used as a reference for prescription in the unit 19 . As five variables were evaluated for each prescribed drug, the total number of errors could exceed the total number of prescribed drugs. The dose was considered incorrect and therefore classified as prescribing errors when presented a deviation of ± 10% of the recommended dose 9, 20 . A margin of ± 10% of the lower and upper limit was used for medicines whose rates are indicated by ranges. The variation of newborn daily weight listed in their files was used to calculate the dose. The other variables (interval, route of administration, diluent and infusion rate) were classified as prescribing errors when they were not in accordance with the specifications of the baseline data used for analysis. The variables diluent and infusion rate were assessed only when necessary, such as for intravenous drugs, for example.
When the variables were necessary according to the Neofax, but they were not prescribed, they were classified as missing variables. No lack of variable was considered a prescribing error. Drugs were classified according to the Anatomical Therapeutic Chemical (ATC) classification of the World Health Organization 21 .
Statistical analysis
The data was analyzed using SPSS 17.0 (SPSS Inc., Chicago, USA). Comparisons between groups of preterm and term infants were performed by using the Student t-test or Mann-Whitney test. To evaluate the relationship between qualitative variables we used the chi-square (χ²) test. When the expected frequencies were less than five, Fisher's exact test was used to determine significance. To assess the types of medication errors in relation to the GA, logistic regression was used for obtaining the odds ratio (OR) at a 95% confidence interval (95%CI). To verify the correlation between the number of errors and the characteristics of the newborn, the Spearman correlation analysis was done. Absolute and relative frequencies of errors were calculated. The significance level considered in all statistical analysis was 5%.
Results
During the collection period, 224 neonates were admitted to the neonatal ICU. Of these, 151 met the inclusion criteria. One patient was excluded because he had only a single prescribed drug which was not included in the base used for analysis. Thus, 150 patients remained, most were male (n = 90). Two patients had two admissions and one patient had three admissions to the unit. 25 deaths occurred during the study period. Table 1 describes the characteristics of the newborns and their prescriptions.
Data of 489 prescription order forms were collected. 11 prescription order forms were excluded because they contained only medication items that were not included in the database used. The remaining prescription order forms (n = 478) contained 1,616 items of medications; however 125 items were excluded because they do not appear in the Neofax database. The analyzed medication items (n = 1,491) represented 46 different drugs. The intravenous route was the most prescribed (n = 1,326), followed by oral (n = 149) and subcutaneous (n = 1). Variables evaluated and prescribed totaled 5,522. There were 1,643 missing variable relating to route of administration (n = 15), interval (n = 75), diluents (n = 718) and infusion rate (n = 835). Among the prescribed drugs (n = 1,491), 648 errors were found, corresponding to a rate of 43.5% prescribing errors. The percentage of prescribed drugs with one or more errors was 36.7% (547/1,491). There was no significant difference in the number of errors between the first three moments of hospitalization, but the occurrence of errors was significantly lower (p < 0.0001) at the time of hospital discharge compared to the first three moments of hospitalization. Most errors involved medication items prescribed for intravenous (94.8%) and oral (5.2%) routes of administration.
The number of errors was significantly higher in preterm infants (p = 0.012, χ 2 test). The frequencies of errors per prescribed variable according to gestational age are shown in Table 2 . Considering the total of analyzed variables, the chance of occurrence of errors was significantly higher in preterm infants compared to term infants. The most frequent errors were diluent, dose, and interval, regardless of gestational age.
Regarding the correlation of the clinical characteristics of newborns (weight at admission, GA and SNAPPE-II) with the number of errors, the results were significant only in the group of preterm infants. There were moderate negative correlations between number of errors and the weight at admission (rs = -0.4849, p < 0.0001) and GA (rs = -0.3187, p < 0.0009). A weak positive correlation (rs = 0.2982, p < 0.0019) was observed with SNAPPE-II.
Considering the total number of errors, the classes of medication with the highest number of errors were anti-infectives for systemic use (n = 296) and drugs for nervous (n = 139) and cardiovascular (n = 96) systems (Table 3) .
In relation to the class of anti-infective agents, ampicillin and gentamicin were the most prescribed and also more involved in prescribing errors in this study, and the majority of them occurred in preterm infants (Table 4) . Of drugs that act on the nervous system, fentanyl (n = 76), morphine (n = 30) and phenobarbital (n = 22) were the most involved in errors. Regarding the cardiovascular system, furosemide (n = 44) and milrinone (n = 6) were respectively the diuretic and the inotropic more involved in prescribing errors. The frequency of errors by prescribed drug variable, according to gestational age and Anatomical Therapeutic Chemical Classification, is shown in Table 4 .
Discussion
In accordance with the findings of several authors 1, 3, 7, 8, 11, 13, 22 , this study also shows that medication errors are common in a Brazilian neonatal ICU. Although most of these errors do not cause damage and are preventable within the neonatal unit 3, 7, 8, 20 , some of them can cause severe injury and even death 13, 23 . Studies of medication errors are extremely important because they help to identify the most vulnerable stages of the process 11 and may contribute to the development of actions to promote their reduction. However, comparisons between the results of the studies are not always possible due to the use of different definitions of medication errors and different methods of analysis 11, 24, 25, 26 . *** p-value < 0.05 indicating statistically significant differences among gestational ages (logistic regression).
95%CI: 95% confidence interval.
Many studies have called attention to the prescription phase, since most medication errors occur during this phase 1, 7, 8, 9 . The rate of prescribing errors observed in this study (43.5%) was higher than that found by Campino et al. 20 (20.7%). However, these authors did not assess diluent and infusion rate errors, as we did in this study. Regarding the percentage of pre- 
Anti-infectives for systemic use
Ampicillin ( (34) 38 (1) 180 (85) 38 (14) 164 (3) 31 (2) 858 (195)
Oxacillin (ev) 15 (1) 21 (7) 15 (0) 21 (1) (4) Vancomycin (ev) 13 (0) 5 (1) 13 (0) 5 (0) 12 (0) 5 (0) 11 (2) 5 (0) 69 (3) Zidovudine (ev/or)
Total 434 (111) 147 (14) 431 (36) 146 (13) 231 (90) 81 (20) 220 (9) 67 (3) 1,757 (296)
Nervous system
Caffeine (or) 16 (1) 5 (4) 16 (0) (0) 14 (0) 28 (11) 25 (7) 27 (0) 25 (0) 193 (18) Dopamine (ev) 16 (0) 16 (0) 10 (0) 13 (0) 15 (4) 16 (2) 15 (0) 16 (0) 117 (6) Epinephrine (ev) 10 (1) 5 (1) 9 (0) 4 (0) 6 (2) 4 (0) 4 (0) 4 (0) 46 (4) Furosemide (ev/or) 10 (6) 20 (7) 9 (8) 20 (19) 1 (1) (10) 108 (14) 66 (8) 80 (21) 66 (21) 85 (21) 52 (0) 70 (1) 609 (96) Respioratory system Aminophylline (ev/or) 200 (41) 12 (2) 199 (1) 12 (0) 23 (23) 2 (2) 12 (6) (2) 199 (1) 12 (0) 23 (23) 2 (2) 12 (6) 1 (0) 461 (75) (continues) Ranitidine (ev/or) 33 (9) 28 (10) 33 (4) 28 (5) 2 (0) 4 (0) 1 (0) 2 (0) 131 (28) Total 52 (11) 37 (10) 47 (4) 36 (5) 4 (1) 
Genitourinary system and sex hormone
Blood and blood forming organs Enoxaparin (sc) 0
Systemic hormonal preparations, excluding sex hormones and insulins
E: absolute frequency of errors; n: total number of prescribed variables; ev: intravenous; NA: not applicable to the prescribed drug; or: oral; sc: subcutaneous.
scribed items that had at least one error, the rate de 36.7% reported in the present study is within the variation range reported by Campino et al. 20 (19.2%), Pallas et al. 9 (39.5%) and Deshpande 27 (52%). Even higher rates (78.1%) were reported by Alagha et al. 28 in a study conducted in a pediatric ICU. As referenced by other authors 1, 8 , in this study the majority of errors (94.8%) were related to prescribed drugs for intravenous use. Within this context, it is important to note that the drug dispensing system by unit dose presents many advantages, among which the reduction of medication errors stands out 29 .
The stratification by GA of the patients hospitalized in the neonatal ICU considered in this study showed that preterm infants experienced more prescribing errors and that prematurity is a risk factor for the occurrence of this type of error, either by prescribed variable (OR = 1.264, Table 2 ), or by prescribed drug (OR = 1.4, Table 3 ).
Special attention should be given to this finding, since the critically ill and younger newborns are less able to mitigate such errors 1 . Other authors 16, 30, 31 have also shown that preterm infants and those in need of complex medical care had higher rates of errors.
Among the errors found in this study, the diluent stood out because it accounted for 44.9% of the total. Serra et al. 32 recorded no diluent error, but only errors of dose and interval in a neonatal ICU. The evaluation of the prescribed diluent is often not included in the analysis of prescription and usually reported in studies on errors in the administration phase 3, 33 . Therefore evaluating this type of error is very important, since the use of an inappropriate diluent can lead to a reduced stability and activity of the drug, and possible precipitation 33 .
Dose and interval errors have also been reported as common prescribing errors 1, 7, 8, 9, 13, 20, 32 .
Chedoe et al. 11 , in a systematic review of the literature on medication errors in neonatal ICUs, reported that the dose error is the most frequent type of error. However, in this study the incorrect dose was the second most frequent type of error. This is justified, in part, because the prescribed diluent has been evaluated in this study. Nevertheless, errors in dose and interval found here, 38.4% and 13.6% respectively, are close to the values of 35.2% and 18.1% reported by Simpson et al. 8 . Kaushal et al. 1 , in a study of medication errors in pediatrics found that among the potential adverse events, ie, errors that could cause harm to patients, the most common were dose, interval and route of administration. The present study showed that there was a negative correlation between the weight of the newborn at admission in the neonatal ICU and the number of medication errors for the preterm infants, and also a greater chance (OR = 1.55) of dosing errors compared with term infants. The study by Kanter et al. 34 also reported an inverse linear relationship between birth weight and the rate of errors. As important as the dose, the interval between them should also be monitored carefully, since it is necessary to adjust the dose to the age of the newborn to medications such as antimicrobials 35 . The frequency of errors in dose and interval in a neonatal ICU can be associated with the use of weight, body surface, and gestational and chronological ages in the calculations of the dose and interval 2, 6 . Therefore, prescribers should be aware of these variables, otherwise inadequate doses may be prescribed 35 . Furthermore, another peculiarity of neonatal pharmacotherapy is the frequent prescription of off-label or unlicensed medicines, ie those that are not approved for this age group, and are therefore a great challenge to neonatologists 2, 36 .
Error in the infusion rate was also found in the present study, althought in a smaller proportion (3.1%). Other authors have reported higher rates for this type of error, but the data from these studies were obtained in the evaluation of the preparation and administration of medications 16, 24, 32, 37 .
Although in this study, the omission of variables (route of administration, interval, diluent and infusion rate) was not considered a prescribing error, these findings lead to reflection, and may be subject to intervention, since the omission can lead to error. Cousins et al. 33 suggest that one of the causes of errors in the infusion rate and diluent for drugs administered intravenously, may be associated with the fact that these variables are not often specified in the prescription, being at the discretion of the healthcare worker who will administer the medication to establish the diluent and infusion rate. In a recent protocol published by Ministry of Health of Brazil 38 it is recommended that these variables must be properly specified in the prescription.
In concordance with the data reported by other authors 1, 3, 9, 22, 24 , the results of this study also showed that the class of anti-infective for systemic use and drugs for cardiovascular and nervous systems are more involved in errors. This is probably due to the frequent use of these drugs in the neonatal ICU, since the risk of occurrence of error is directly proportional to the frequency of use 22 . This may also explain why the number of errors at the time of discharge from the neonatal ICU was lower when compared with the other moments, since the number of medication items prescribed was lower at discharge from the neonatal ICU. Regarding anti-infective agents, Simpson et al. 8 also reported gentamicin as the parenteral drug most involved in errors. Ampicillin and gentamicin are drugs that are often prescribed in the neonatal ICU, as part of empirical antibiotic therapy 36, 39 . Serious adverse effects of nephrotoxicity and ototoxicity are well known in response to aminoglycosides 3 and therefore, attention should be given when prescribing these drugs.
Fentanyl, morphine and phenobarbital were also frequently involved in errors, which is consistent with reports by other authors 3, 8 . Errors involving morphine sulfate are potentially lethal in children 24 . Differently from what happened in the classes of anti-infectives and drugs that act on the nervous system, most errors for drugs acting on the cardiovascular system occurred in term infants, and the drug with the highest number of errors was furosemide. It is noteworthy for this class of medicines that milrinone, along with other drugs mentioned in this study (fentanyl, morphine, midazolam, chloral hydrate, insulin and amiodarone) are on the list of high-alert medications, which have an increased risk of causing harm to the patient if not used properly 40 .
The results of this study reinforce the need for studies on medication errors in the neonatal ICU, since these errors are common. The safety of the newborn should be the goal of the entire care team and measures should be evaluated and implemented in order to prevent the occurrence of medication errors. Measures such as computerized physician order entry, presence of clinical pharmacist on the unit and improved communication between pharmacists, nurses and doctors, have been shown to be effective in reducing errors 7 .
Limitations of this study include the following: its retrospective design, which prevents the researchers from contacting the prescriber to find out whether there was any clinical situation justifying this gap; the definition of dose error as 10% dose errors deviation from the recommended dose; the number of drugs excluded from the analysis because Neofax does not include them; the lack of evaluation of the impact of the errors found; the lack of evaluation of the prescribed electrolytes; the failure to consider as a prescribing error the lack of a necessary variable in the prescription; and its limitation to a single hospital. Despite the limitations of this study the findings of this study may contribute to the implementation of necessary actions for improvement in newborn care.
Conclusion
Medication errors were common, especially in preterm infants. The most frequent types of errors were diluent, dose and interval. The drug classes most involved were anti-infective agents and drugs that act on the nervous and cardiovascular systems. The data from this study may help to raise the awareness of health professionals about the need to establish measures for reducing medication errors in evaluated neonatal intensive care units. 
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